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A B S T R A C T
Objectives: To assesses whether automated brain image analysis with quantiﬁ-
cation of structural brain changes improves diagnostic accuracy in a memory clinic setting.
Methods: In 42 memory clinic patients, we evaluated whether automated quantiﬁcation of brain tissue volumes, hippocampal volume and white matter lesion
volume improves diagnostic accuracy for Alzheimer's disease (AD) and frontotemporal dementia (FTD), compared to visual interpretation. Reference data were
derived from a dementia-free aging population (n=4915, aged>45 years), and were expressed as age- and sex-speciﬁc percentiles. Experienced radiologists
determined the most likely imaging-based diagnosis based on structural brain MRI using three strategies (visual assessment of MRI only, quantitative normative
information only, or a combination of both). Diagnostic accuracy of each strategy was calculated with the clinical diagnosis as the reference standard.
Results: Providing radiologists with only quantitative data decreased diagnostic accuracy both for AD and FTD compared to conventional visual rating. The com-
bination of quantitative with visual information, however, led to better diagnostic accuracy compared to only visual ratings for AD. This was not the case for FTD.
Conclusion: Quantitative assessment of structural brain MRI combined with a reference standard in addition to standard visual assessment may improve diagnostic
accuracy in a memory clinic setting.
1. Introduction
Dementia is a clinical syndrome caused by various brain diseases, of
which Alzheimer's disease (AD), vascular dementia and frontotemporal
dementia (FTD) are most frequent (Ferri et al., 2005). In early onset
dementia AD is the most common cause (approximately 34%) but FTD
is also relatively prevalent (12%) (Van der Flier and Scheltens, 2005),
which frequently causes a clinical diagnostic dilemma. Dementia is
diagnosed clinically as a cognitive disorder interfering with activities of
daily life according to core clinical criteria. Imaging biomarkers, cog-
nitive proﬁling, genetic information, and cerebrospinal ﬂuid (CSF)
biochemistry features provide supportive evidence for diﬀerential di-
agnosis (Dubois et al., 2007; McKhann et al., 2011). Yet, the NIA-AA
criteria (McKhann et al., 2011) for AD diagnosis only have a sensitivity
of 65% for distinguishing probable AD from FTD, with considerable
overlap in clinical symptoms, especially in early disease stages (Harris
et al., 2015). Early and accurate identiﬁcation of dementia's underlying
causes is important for proper and tailored patient management as well
as upcoming disease-modifying treatment options (Ballard et al., 2011;
Mattila et al., 2012).
By visualizing structural brain changes associated with speciﬁc pa-
thological substrates, Magnetic Resonance imaging (MRI) plays an
important role in dementia diagnosis and subtype diﬀerentiation
(Vernooij and Smits, 2012). MRI interpretation in dementia diagnosis
can be challenging, as early brain abnormalities may be diﬃcult to
detect visually, especially in early stages of the disease. Additionally,
brain changes due to a neurodegenerative disorder may be diﬃcult to
distinguish from those related to normal aging.
One way to potentially improve diagnostic accuracy and conﬁdence
is to quantify brain structures from an individual patient and compare
these to age- and sex-speciﬁc reference data from a healthy population
(Brewer, 2009; Ross et al., 2015). Although several MR brain quanti-
ﬁcation methods are now becoming available and gradually ﬁnding
their way into clinical applications (Ross et al., 2015; Brewer et al.,
2009; Ross et al., 2013), there is no clear concept on how they should
be implemented in radiology reading or reporting practice. Whether
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quantitative information improves diagnostic accuracy, and, if so, it can
be used in isolation or should be considered together with other ima-
ging information is not known.
In this study, we implemented automated quantiﬁcation of brain
tissue volumes, hippocampal volumes and white matter lesion volumes
in our memory clinic and compared these volumes to population re-
ference data. Our aim was to compare three diﬀerent strategies, namely
visual rating of brain MR scans only, quantitative normative assessment
only, and a combination of both visual rating and quantitative assess-
ment, to the reference standard of multidisciplinary clinical consensus
diagnosis, and to assess diagnostic agreement of these strategies be-
tween two observers.
2. Materials and methods
2.1. Patient population
Between December 2009 and September 2011, all new patients who
visited our memory clinic and who (Ferri et al., 2005) underwent MRI
as part of clinical work up, and (Van der Flier and Scheltens, 2005)
received a clinical diagnosis of AD, FTD or MCI, were eligible for this
retrospective study. Our memory clinic is specialized in early onset
dementia, hence we see a higher proportion of rare dementias (such as
FTD) and patients with early disease onset. A total of 42 patients were
eligible, 21 patients with AD, 15 with FTD, and 6 with MCI. The clinical
diagnosis was based on expert panel consensus using standard diag-
nostic criteria (McKhann et al., 2011; Rascovsky et al., 2011) and all
available information, including neuropsychological information, brain
MRI, CSF (if available) and neurological examination.
Brain MRI scans were acquired at 3.0 T (GE Healthcare, US), ac-
cording to a standardized protocol, including sagittal 3D T1-weighted
(T1w) inversion recovery (IR) fast spoiled gradient recalled echo
(FSPGR) scans with axial and coronal reconstructions (perpendicular to
the long axis of the hippocampus); ﬂuid attenuated inversion recovery
scans (FLAIR); and T2w scans. Supplementary Table 1 provides all re-
levant MRI parameters.
2.2. Reference population
Reference data were obtained from 4915 non-demented participants
(mean age 64 yrs., range 45.7–100.0) from a population-based long-
itudinal study among community dwelling subjects (Hofman et al.,
2015; Ikram et al., 2015)
All scans were acquired on a single 1.5 T MR imaging system (GE
Healthcare, US). The imaging protocol (Supplementary Table 1) in-
cluded a 3D T1w IR-FSPGR, a proton density (PD)–weighted sequence
and a FLAIR sequence. The PD sequence was applied with a long TR,
resulting in bright CSF as in T2w images.
2.3. Brain tissue, white matter lesion and hippocampal volume
quantiﬁcation
Gray matter (GM), white matter (WM), white matter lesions (WML)
and CSF segmentation was performed with a fully automated method
(Vrooman et al., 2007) extended with WML segmentation (de Boer
et al., 2009). This involved the segmentation of CSF, GM, and WM by an
atlas-based k-nearest neighbor classiﬁer on the MRI data. The classiﬁer
was trained by registering brain atlases to the subjects (Vrooman et al.,
2007). The GM classiﬁcation was then used to determine a WML in-
tensity threshold value in a FLAIR scan. Applying this threshold to the
FLAIR scan yielded the WML segmentation (de Boer et al., 2009). Total
brain volume was calculated by summing WM, GM and WML volumes.
Intracranial volume was deﬁned as the sum of total brain volume and
CSF volumes. T1w scans were processed using FreeSurfer (4.5.0) to
obtain hippocampal volumes (Dale et al., 1999; Desikan et al., 2006).
2.4. Lobar volume quantiﬁcation
To obtain lobar brain volumes, a multi-atlas approach was used
(Vibha et al., 2018). Six template scans (atlases) were created in which
the frontal, parietal, temporal and occipital lobes of the left and right
hemisphere were outlined (Bokde et al., 2005). These atlases were non-
rigidly registered (Klein et al., 2010) to a subject brain MRI and labels
were assigned to each voxel using majority voting. By combining this
lobar mask with the original tissue segmentation, volumes for each
brain lobe were calculated (Ikram et al., 2010). Fig. 1 provides an ex-
ample of the atlas and segmentation results. Intracranial volume (ICV)
was used to correct for inter-individual diﬀerences in head size, by
dividing each volume by ICV in each subject.
2.5. Visual inspection
All patient tissue and lobar segmentation results were visually
checked for segmentation errors, revealing no substantial errors. No
manual corrections were performed, as this would ultimately hamper
translating the workﬂow to clinical practice.
For the 4945 reference subjects, outliers (deﬁned as 2.0 standard
deviations from the mean) were found for total brain (n=134), white
matter lesion (n=66) and hippocampal volumes (n=172). Outliers
were visually checked and if caused by segmentation errors, bad scan
quality or signiﬁcant structural abnormalities, scans were excluded
(n=30) resulting in 4915 scans for creating reference curves.
2.6. Reference curves
Age- and sex-speciﬁc percentile curves were generated for each
quantitative parameter (total brain, lobar brain, hippocampal and WML
volumes) using the LMS method (Cole and Green, 1992). Percentile
curves (Fig. 2) were generated using the VGAM (1.0–0) package for R
(3.2.3).
For each patient, the age-appropriate percentile value, referred to as
“Volume percentile” (Vperc) was calculated for each of the brain vo-
lumes, and plotted on the reference curves.
2.7. Rating strategies
Two experienced neuro-radiologists (M.S. and M.W.V., each with
more than three years of experience in reading memory clinic scans),
blinded to all patient characteristics except age and sex, independently
provided an imaging-based diagnosis. To reﬂect a realistic clinical
scenario, the raters selected a diagnosis from three categories: AD, FTD,
or alternative diagnosis (including no dementia). They were unaware of
the proportion of AD, FTD and MCI in the sample.
We assessed three diagnostic strategies:
Fig. 1. Brain segmentation.
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Firstly, a visual interpretation of the brain MR imaging scans was
performed. Raters interpreted patterns of atrophy and presence of
vascular lesions using the 3D T1w FSPGR (including coronal reformats),
the T2w, and the T2w-FLAIR sequences by applying standardized visual
rating scales such as the global cortical atrophy scale and Koedam scale
for lobar atrophy, the medial temporal atrophy scale for hippocampal
atrophy, and the Fazekas scale for WML (Scheltens et al., 1998;
Scheltens et al., 1995; Pasquier et al., 1996; Koedam et al., 2011). Each
rater independently based their ﬁnal diagnosis on the combination of
these visual ratings.
Secondly, both raters were provided with Vperc only and provided a
diagnosis solely based on these. Raters were left free how to interpret
the Vperc (no cut-oﬀ values prescribed). As quantitative normative
assessment is an evolving concept, we made a deliberate choice not to
provide the raters with directions or cut-oﬀ values, to be able to assess
the eﬀect of having quantitative information available for diagnosis.
Additionally, assessing relative values, i.e. Vperc of one structure
compared to other structures, is equally important as applying absolute
cut-oﬀs to separate regions.
Thirdly, the raters reviewed the brain MRI together with the asso-
ciated Vperc to come to a diagnosis.
The above strategies were each separated by three months, with
patient identiﬁcation numbers altered to ensure that current assess-
ments could not be related to previous assessments.
2.8. Statistical analysis
For all combinations of assessment strategy and rater, diagnostic
accuracy for AD and FTD diagnosis was determined as the sum of the
true positive and negative cases divided by the total number of cases.
Diﬀerences in accuracies between strategies for each diagnosis and for
each rater were assessed with McNemar tests. Inter-rater agreement per
strategy was calculated using Cohen's κ. In addition to the cross-sec-
tional analysis, we also used follow up information (mean follow up
2.8 yrs., range 0–6.1 years) for possible change in clinical diagnosis and
recalculated diagnostic accuracies. Finally, to assess the performance of
subjective interpretation of the quantitative information by the clin-
icians (i.e. without speciﬁc cut-oﬀs) in comparison to the use of abso-
lute cut-oﬀs, we determined optimal cut-oﬀ values to discriminate be-
tween diagnoses, based on Vperc of relevant brain regions (MCI versus
AD & FTD based on hippocampal Vperc; FTD versus AD & MCI based on
frontal and temporal Vperc, and AD versus FTD & MCI based on
hippocampal and parietal Vperc). For each cut-oﬀ point, we calculated
the distance from the maximum sensitivity and speciﬁcity as follows:
distance= √[(1 – sensitivity)2+ (1 – speciﬁcity)2], and subsequently
located the point where distance was minimal. We compared the di-
agnostic accuracy at this optimal value with the performance of both
raters.
We separately assessed the correlation between visual rating of
WML burden (Fazekas score (Scheltens et al., 1998)) and automated
quantiﬁcation. Spearman rank correlation was calculated between the
raters' Fazekas scores and total WML volume (% of ICV) and between
Fazekas scores and the WML Vperc.
Statistical analyses of diagnostic accuracy (i.e. of assessment
strategy; rater; and optimal cut-oﬀ values) and of inter-rater agreement
were performed with SPSS version 22. To assess diﬀerences in ac-
curacies between strategies for each diagnosis and for each rater,
Python version 2.7.11+ and the McNemar implementation of the
statsmodels python package (version 0.6.1) were used. An α of 0.05 was
considered as threshold for statistical signiﬁcance.
3. Results
Table 1 shows patient characteristics. Mean age of AD patients was
66.1 +/− 8.5 years, and 43% were female; FTD patients were on
average younger (60.0 +/− 6.5 years), and 40% were female.
Tables 2 shows regional brain and lesion volumes expressed as
percentage of intracranial volume (%ICV), and age appropriate Vperc,
respectively. Diﬀerences in regional brain volumes between patient
groups were more evident when expressed as Vperc than as %ICV.
These diﬀerences were evident in brain regions that are known to be
aﬀected in AD and FTD (i.e. hippocampus, frontal and temporal lobes).
Table 3 shows diagnostic accuracy for AD and FTD of both observers
and all three strategies. Table 4 shows the results of the comparisons of
accuracy between strategies (McNemar test). Neither for AD nor FTD
did the use of quantitative information alone improve diagnostic ac-
curacy compared to visual assessment only. Moreover, for FTD this
strategy led to a signiﬁcantly worse accuracy (p =/<0.01 for both
raters). For AD, diagnostic accuracy improved with the combined vi-
sual/quantitative strategy compared to visual assessment only (73.8%
for both raters compared to 59.5% in rater A (p= .03) and 66.7% in
rater B (p= .45) for visual only strategy). For FTD, visual assessment
only performed slightly better than the combined visual/quantitative
strategies, but this diﬀerence was not statistically signiﬁcant (p= .4);
diagnostic accuracy was high with both strategies.
During a mean follow up of 2.8 years (0.0–6.1 years), 7 of the 42
initial diagnoses had changed. This did not lead to a change in accuracy
of any of the strategies (Supplementary Table 2).
Supplementary Table 3 shows the comparison of automated classi-
ﬁcation accuracy using optimal cut-oﬀ values with rater classiﬁcation.
Especially for FTD using these optimal cut-oﬀ values improves perfor-
mance. The correlation between Fazekas score (0–3) and total WML
Fig. 2. Percentile curve for total brain volume.
Table 1
Patient characteristics.
MCI (N=6) AD (N=21) FTD
(N=15)
Total
(N=42)
Age in y,
mean (SD)
63.2 (8.5) 66.1 (8.5) 60.0 (6.5) 63.5 (8.1)
Gender
male:female
2:4 12:9 9:6 23:19
Duration in y,
mean (SD)
1.1 (1.8–3.6) 2.1 (1.1–3.3) 2.1 (1.5–3.0) 2.1 (1.3–3.2)
MMSE,
median (IQR)
25.5
(23.0–26.8)
24.0
(22.0–25.0)
25.5
(22.5–29.0)
24.5
(22.3–27.0)
MCI=mild cognitive impairment, AD=Alzheimer's disease,
FTD= frontotemporal dementia, SD= standard deviation, IQR= interquartile
range.
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volume expressed as %ICV was high, with Spearman correlation coef-
ﬁcient of 0.75 (for both raters, p < .01). This correlation dropped to
0.57 (p < .01) for Fazekas and Vperc WML, with most variation in
Vperc for the Fazekas scores of 0 and 1 (Supplementary Fig. 1).
Interrater agreement between both observers was 69% (kappa 0.55,
p < .01) when using visual assessment only, 62% (kappa 0.42,
p < .01) when solely using quantitative information, and 67% (kappa
0.5, p < .01) when combining visual and quantitative assessment for
diagnosis.
4. Discussion
In the setting of a memory clinic, we evaluated how adding quan-
titative volumetric brain data and population reference data aﬀect the
accuracy of radiologists' MR imaging-based dementia diagnosis.
Providing experienced radiologists with only quantitative data sig-
niﬁcantly decreased diagnostic accuracy compared to conventional vi-
sual rating methods. Yet, the combination of quantitative data with
visual rating of brain MR imaging suggested better diagnostic accuracy
of AD, but not that of FTD.
Strengths of our study are the large dataset of reference subjects
from the general population, enabling us to compare patient data to age
and sex-speciﬁc normative volumetric data. The automated algorithms
that were used can be easily implemented in a general clinical setting.
We normalized for intracranial volume, as diﬀerences in head size
would otherwise preclude a fair comparison between individuals. This
is illustrated by our ﬁndings in WML: we found a high correlation be-
tween the visual Fazekas score and automated absolute WML volume,
which decreased when WML were age- and sex-adjusted as volume
Table 2
Median (IQR) of brain, lobar, hippocampal and white matter lesion volumes expressed as percentage of intracranial volume (%ICV) and as volume percentiles
(Vperc) for the diagnosis groups.
Volume %ICV Vperc
MCI AD FTD MCI AD FTD
Total brain 84.8
(84.1–86.6)
83.6
(82.5–84.9)
82.0
(80.9–84.3)
86.6
(52.5–98.2)
73.8
(25.6–88.5)
16.2
(4.2–61.0)
WML 1.0
(0.3–1.7)
1.1
(0.3–2.0)
0.4
(0.2–0.9)
78.0
(67.9–95.2)
88.5
(75.4–95.0)
82.4
(54.2–96.3)
Frontal right 14.2
(14.0–14.4)
13.8
(13.4–14.3)
13.2
(12.5–14.3)
30.4
(21.8–33.1)
10.6
(5.1–47.4)
0.9
(0.0–46.9)
Frontal left 14.3
(14.2–14.5)
14.0
(13.3–14.9)
13.2
(12.0–14.9)
29.8
(13.7–42.4)
19.8
(3.8–73.9)
0.6
(0.0–68.8)
Temporal right 8.6
(8.4–9.3)
8.3
(7.9–8.5)
7.9
(7.9–8.9)
63.6
(26.0–96.5)
19.2
(4.8–47.1)
4.9
(2.3–74.2)
Temporal left 8.3
(8.0–8.4)
7.7
(7.5–7.9)
7.4
(6.9–7.9)
89.3
(57.2–94.1)
29.9
(17.6–50.6)
6.4
(0.2–39.2)
Parietal right 8.7
(8.6–9.0)
8.8
(8.4–9.1)
8.9
(8.1–9.4)
78.8
(60.1–95.5)
82.0
(51.3–98.0)
93.1
(25.3–99.8)
Parietal left 9.3
(9.1–9.4)
9.3
(9.1–9.7)
9.7
(9.4–10.1)
81.8
(64.2–90.4)
78.7
(49.1–98.4)
96.8
(83.0–99.7)
Occipital right 5.5
(5.2–5.8)
5.3
(5.2–5.7)
5.4
(5.2–6.0)
69.1
(45.4–91.3)
60.4
(37.6–91.9)
59.2
(32.5–98.3)
Occipital left 5.4
(5.2–5.7)
5.3
(5.0–5.5)
5.5
(5.3–5.8)
85.9
(62.0–98.6)
72.7
(29.0–86.8)
88.5
(72.1–98.6)
Right hippocampus 0.357
(0.310–0.388)
0.282
(0.258–0.322)
0.301
(0.276–0.338)
28.3
(7.9–69.8)
2.28
(0.7–12.4)
2.7
(0.6–14.6)
Left hippocampus 0.363
(0.262–0.402)
0.290
(0.247–0.328)
0.290
(0.263–0.313)
32.3
(0.7–63.5)
3.2
(0.4–14.0)
1.8
(0.2–6.1)
IQR= interquartile range
%ICV=percentage of intracranial volume.
Vperc= volume percentile (age appropriate percentile value calculated for each of the volumes, plotted on the reference curves).
MCI=mild cognitive impairment, AD=Alzheimer's disease, FTD= frontotemporal dementia.
WML=white matter lesion.
Table 3
Accuracy of the diﬀerent rating scenarios per observer.
Observer Disease Scenario TP+TN/all Accuracy
A AD Visual only 25/42 59.5
Quantitative only 22/42 52.4
Combined 31/42 73.8
FTD Visual only 38/42 90.5
Quantitative only 28/42 66.7
Combined 35/42 83.3
B AD Visual only 28/42 66.7
Percentiles only 26/42 61.9
Combined 31/42 73.8
FTD Visual only 36/42 85.7
Combined 33/42 78.6
AD=Alzheimer's disease; FTD= frontotemporal dementia; TP= true positive;
TN= true negative.
Accuracy was calculated as (TP+TN/all subjects)*100%.
Table 4
Comparison of the three diﬀerent strategies.
AD FTD
Observer Comparison Higher
accuracy for
P* Higher
accuracy for
P*
A visual vs Vperc Visual 0.55 Visual 0.01
A visual vs
combined
Combined 0.03 Visual 0.4
A Vperc vs
combined
Combined 0.02 Combined 0.04
B visual vs Vperc Visual 0.8 Visual 0.002
B visual vs
combined
Combined 0.45 Visual 0.4
B Vperc vs
combined
Combined 0.27 Combined 0.02
Abbreviations: Vperc=Volume percentile; *= p-value for comparison of di-
agnostic accuracy between two strategies (Mc Nemar test).
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percentile. Lower visual WML scores in particular showed a wide range
of variation in percentile WML load. Although this needs further in-
vestigation, it suggests that quantifying WML relative to normal aging
may be more sensitive for identifying subjects with a ‘higher than
normal’ relative WML load.
There are also limitations that need to be considered. Firstly, the
sample size was modest. This is inherent to the nature of the sample, as
it included only patients with early onset (< 65 years) dementia, which
is less prevalent than late onset dementia. We speciﬁcally selected this
sample because diagnosis in early onset dementia is much more chal-
lenging than in late onset dementia. A second limitation is that subjects
in the reference population were all scanned on a single scanner using
the same scan parameters. Patients were scanned using a diﬀerent
scanner, with diﬀerent ﬁeld strength and scan parameters. These dif-
ferences may hamper comparison between subjects and application of
absolute volume cut-oﬀ values. However, relative comparisons of vo-
lumes between regions within one patient will still be valid. Inter-
scanner eﬀects have been studied (Cover et al., 2011; Wolz et al., 2014;
Opfer et al., 2016; Abdulkadir et al., 2011; Kruggel et al., 2010) and
future studies should focus on developing quantitative markers that are
robust to inter-scanner diﬀerences (Puonti et al., 2013; van Opbroek
et al., 2015). Finally, as reference standard we used the clinical diag-
nosis based on established criteria and including the full clinical pic-
ture. Although this is the most optimal diagnosis in the setting of lack of
pathological conﬁrmation, the clinical diagnosis may still be wrong,
especially in the early disease stages. We speciﬁcally investigated this
issue by repeating analyses with available follow up data and found that
diagnostic accuracy did not change substantially.
Another issue is that patients may have mixed or multiple pathol-
ogies, which is diﬃcult to detect clinically, but may be detected better
by volumetric quantiﬁcation. Our current study design would not be
able to show this potential advantage. Having a group of MCI patients
as a control condition instead of cognitively normal subjects or ‘healthy
controls’ may also have attenuated our ability to distinguish the three
groups, since MCI is a heterogeneous group among which subjects may
have brain changes that are in the spectrum of AD abnormalities. Yet,
this composition of the patient group optimally reﬂects the clinical
setting, as MCI is a very common alternative diagnosis in a memory
clinic population.
Of greater importance than the absolute diagnostic performance is
the comparison between the three strategies. For AD the best diagnostic
strategy appears to be using quantitative information combined with
visual inspection, providing the highest accuracy and highest interrater
agreement. The addition of quantitative information to visual inspec-
tion may provide added value to the experienced rater, either by pro-
viding clues for interpreting the quantitative information or by di-
recting attention to brain regions that may only show subtle changes on
visual inspection. The added value of quantitative information was
solely present for diagnosis of AD and not for FTD. This was rather
unexpected, but may be due to patterns of atrophy being more visually
obvious in FTD than in AD, even in the early stage of disease, as evi-
denced by the high diagnostic accuracy of visual inspection alone. At
present, accuracy is not yet suﬃcient for clinical implementation
(ranging from 52.4–66.7% when clinicians subjectively interpreted
quantitative information only and from 73.8–83.3% when they com-
bined quantitative and visual information). Longitudinal imaging may
further improve performance of quantitative assessment, as the ac-
celerated rate of atrophy associated with progression of the disease will
probably be more evident in the quantitative information. Relative re-
gional decreases in volume in particular will facilitate (diﬀerential)
diagnosis (Mak et al., 2015; Scahill and Fox, 2007).
Still, the discrepancy between the value of quantitative information
and visual information for diagnosis seems to be in contrast with other
studies investigating the relationship between qualitative and quanti-
tative assessment of MRI for dementia diagnosis. For example Harper
et al. (Harper et al., 2016) found a high correlation between regional
visual scales and voxel-based morphometry (VBM). Our study was
however not limited to (disease speciﬁc) regions. Moreover, in the
Harper study, VBM results were not corrected for age, which may have
resulted in more exaggerated measures of volume loss, due to both
aging and neurodegeneration, than in our study.
Although vascular dementia patients were not included, we eval-
uated the agreement between a qualitative and quantitative assessment
of WML, which could be used in the context of diagnosing vascular
dementia. The correlation between the visual Fazekas score and auto-
mated absolute WML volume was very high, but decreased when WML
were age- and sex-adjusted (as Vperc). In particular the lower visual
WML scores showed a wide range of variation in percentile WML load.
Although this needs further investigation, this may indicate that
quantitative evaluation of WML against the background of normal
aging may be more sensitive to identifying subjects with a ‘higher than
normal’ relative WML load.
Interestingly, dementia diagnosis based solely on quantitative in-
formation had poor accuracy as well as low concordance between
raters, lower than based on visual inspection alone. We therefore also
evaluated automated classiﬁcation when using optimal thresholds of
the quantitative image features, which did improve on rater accuracy. It
should be noted that selecting optimal cut-points on the data causes
overestimation of the performance. Nevertheless, it suggests that in-
terpretation of percentile curves warrants new guidelines for inter-
pretation, and more experience, to improve diagnostic accuracy. At
present, our results suggest that quantitative image information should
not be used as stand-alone information, without visual inspection of
scans. Future studies should focus on providing cut-oﬀ values to de-
termine ‘signiﬁcant atrophy’ or guidelines on how to interpret the
quantitative information, also to rule out training eﬀects that may arise
due to the novelty of the method. In the current study, we aimed to
simulate the current clinical process, which uses hippocampal volume
and lobar volume as the most important diagnostic imaging markers in
dementia. Our objective was to investigate whether normative values
for these structures improved or at least resembled the accuracy of the
visual assessment. However, research literature has put forward several
potentially speciﬁcally aﬀected structures in neurodegeneration (e.g.
entorhinal cortex and subcortical structures such as caudate and pu-
tamen), and providing percentiles of these structures could potentially
be informative to the raters. This would however introduce additional
hurdles for interpretation and an important learning curve.
Nevertheless, our implementation does provide the opportunity to add
more elaborate and reﬁned features of brain volume loss, which may
ultimately exceed visual rating performance. This process may be ex-
tended by exploiting many more image features or image information
by employing e.g. machine learning or deep learning approaches, which
have received increased interest in recent years and have the potential
to improve subject classiﬁcation. Future eﬀorts could therefore be di-
rected towards training diagnostic classiﬁers based on multiple imaging
markers extracted from the reference data, or directly investigating
which information in the reference imaging data is most informative for
diﬀerential diagnosis. In a challenge comparing performance of com-
puter-aided diagnosis algorithms to classify subjects into normal con-
trols, MCI and AD it was shown that methods including more imaging
biomarkers (e.g. hippocampal volume, shape and texture) performed
best (Bron et al., 2015). Future research should focus on determining
which (combination of) quantitative imaging biomarkers is most in-
formative in computer-aided diagnosis of dementia. In view of our re-
sults it is to be expected that providing reference curves of such imaging
biomarkers, in combination with visual assessment, will provide the
most accurate diagnosis of AD.
In conclusion, this study indicates that age-appropriate percentile
values of automatically quantiﬁed regional brain volumes may improve
accuracy and inter-rater agreement of the radiological diagnosis of AD.
Further studies should focus on overcoming the present technical lim-
itations and on developing guidelines on the interpretation of such
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quantitative biomarkers.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nicl.2018.08.004.
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References
Abdulkadir, A., Mortamet, B., Vemuri, P., Jack Jr., C.R., Krueger, G., Klöppel, et al., 2011.
Eﬀects of hardware heterogeneity on the performance of SVM Alzheimer's disease
classiﬁer. NeuroImage 58, 785–792.
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., Jones, E., 2011. Alzheimer's
disease. Lancet 377, 1019–1031.
Bokde, A.L., Teipel, S.J., Schwarz, R., Leinsinger, G., Buerger, K., Moeller, T., et al., 2005.
Reliable manual segmentation of the frontal, parietal, temporal, and occipital lobes
on magnetic resonance images of healthy subjects. Brain Res Brain Res Protoc. 14,
135–145.
Brewer, J.B., 2009. Fully-automated volumetric mri with normative ranges: translation to
clinical practice. Behav. Neurol. 21, 21–28.
Brewer, J.B., Magda, S., Airriess, C., Smith, M.E., 2009. Fully-automated quantiﬁcation of
regional brain volumes for improved detection of focal atrophy in alzheimer disease.
AJNR Am. J. Neuroradiol. 30, 578–580.
Bron, E.E., Smits, M., van der Flier, W.M., Vrenken, H., Barkhof, F., Scheltens, P., et al.,
2015. Standardized evaluation of algorithms for computer-aided diagnosis of de-
mentia based on structural mri: the caddementia challenge. NeuroImage 111,
562–579.
Cole, T.J., Green, P.J., 1992. Smoothing reference centile curves: the lms method and
penalized likelihood. Stat. Med. 11, 1305–1319.
Cover, K.S., van Schijndel, R.A., van Dijk, R.W., Redolﬁ, A., Knol, D.L., Firsoni, G.B., et al.,
2011. Assessing the reproducibility of the SienaX and Siena brain atrophy measures
using the ADNI back-to-back MP-RAGE MRI scans. Psychiatry Res. 193, 182–190.
Dale, A.M., Fischl, B., Sereno, M.I., 1999. Cortical surface-based analysis. I. Segmentation
and surface reconstruction. Neuroimage. 9, 179–194.
de Boer, R., Vrooman, H.A., van der Lijn, F., Vernooij, M.W., Ikram, M.A., van der Lugt,
A., et al., 2009. White matter lesion extension to automatic brain tissue segmentation
on mri. NeuroImage 45, 1151–1161.
Desikan, R.S., Segonne, F., Fischl, B., Quinn, B.T., Dickerson, B.C., Blacker, D., et al.,
2006. An automated labeling system for subdividing the human cerebral cortex on
mri scans into gyral based regions of interest. NeuroImage 31, 968–980.
Dubois, B., Feldman, H.H., Jacova, C., Dekosky, S.T., Barberger-Gateau, P., Cummings, J.,
et al., 2007. Research criteria for the diagnosis of alzheimer's disease: revising the
nincds-adrda criteria. Lancet Neurol. 6, 734–746.
Ferri, C.P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., et al., 2005.
Global prevalence of dementia: a delphi consensus study. Lancet 366, 2112–2117.
Harper, L., Fumagalli, G.G., Barkhof, F., Scheltens, P., O'Brien, J.T., Bouwman, F., et al.,
2016. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-
mortem conﬁrmed cases. Brain 139, 1211–1225.
Harris, J.M., Thompson, J.C., Gall, C., Richardson, A.M., Neary, D., du Plessis, D., et al.,
2015. Do nia-aa criteria distinguish alzheimer's disease from frontotemporal de-
mentia? Alzheimers Dement. 11, 207–215.
Hofman, A., Brusselle, G.G., Darwish Murad, S., van Duijn, C.M., Franco, O.H.,
Goedegebure, A., et al., 2015. The Rotterdam study: 2016 objectives and design
update. Eur. J. Epidemiol. 30, 661–708.
Ikram, M.A., Vrooman, H.A., Vernooij, M.W., den Heijer, T., Hofman, A., Niessen, W.J.,
et al., 2010. Brain tissue volumes in relation to cognitive function and risk of de-
mentia. Neurobiol. Aging 31, 378–386.
Ikram, M.A., van der Lugt, A., Niessen, W.J., Koudstaal, P.J., Krestin, G.P., Hofman, A.,
et al., 2015. The Rotterdam scan study: design update 2016 and main ﬁndings. Eur. J.
Epidemiol. 30, 1299–1315.
Klein, S., Staring, M., Murphy, K., Viergever, M.A., Pluim, J.P., 2010. Elastix: a toolbox for
intensity-based medical image registration. IEEE Trans. Med. Imaging 29, 196–205.
Koedam, E.L., Lehmann, M., van der Flier, W.M., Scheltens, P., Pijnenburg, Y.A., Fox, N.,
et al., 2011. Visual assessment of posterior atrophy development of a mri rating scale.
Eur. Radiol. 21, 2618–2625.
Kruggel, F., Turner, J., Muftuler, L.T., 2010. Alzheimer's disease neuroimaging initiative.
Impact of scanner hardware and imaging protocol on image quality and compartment
volume precision in the ADNI cohort. NeuroImage 49, 2123–2133.
Mak, E., Su, L., Williams, G.B., Watson, R., Firbank, M., et al., 2015. Longitudinal as-
sessment of global and regional atrophy rates in Alzheimer's disease and dementia
with Lewy bodies. Neuroimage Clin. 7, 456–462.
Mattila, J., Soininen, H., Koikkalainen, J., Rueckert, D., Wolz, R., Waldemar, G., et al.,
2012. Optimizing the diagnosis of early alzheimer's disease in mild cognitive im-
pairment subjects. J. Alzheimers Dis. 32, 969–979.
McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack Jr., C.R., Kawas, C.H.,
et al., 2011. The diagnosis of dementia due to alzheimer's disease: recommendations
from the national institute on aging-alzheimer's association workgroups on diagnostic
guidelines for alzheimer's disease. Alzheimers Dement. 7, 263–269.
Opfer, R., Suppa, P., Kepp, T., Spies, L., Schippling, S., Huppertz, H.J., et al., 2016. Atlas
based brain volumetry: how to distinguish regional volume changes due to biological
or physiological eﬀects from inherent noise of the methodology. Magn. Reson.
Imaging 34, 455–461.
Pasquier, F., Leys, D., Weerts, J.G., Mounier-Vehier, F., Barkhof, F., Scheltens, P., 1996.
Inter- and intraobserver reproducibility of cerebral atrophy assessment on mri scans
with hemispheric infarcts. Eur. Neurol. 36, 268–272.
Puonti, O., Iglesias, J.E., Van Leemput, K., 2013. Fast, sequence adaptive parcellation of
brain mr using parametric models. Med Image Comput Comput Assist Interv. 16,
727–734.
Rascovsky, K., Hodges, J.R., Knopman, D., Mendez, M.F., Kramer, J.H., Neuhaus, J., et al.,
2011. Sensitivity of revised diagnostic criteria for the behavioural variant of fron-
totemporal dementia. Brain 134, 2456–2477.
Ross, D.E., Ochs, A.L., Seabaugh, J.M., Shrader, C.R., 2013. Alzheimer's disease neuroi-
maging I. Man versus machine: comparison of radiologists' interpretations and neu-
roquant(r) volumetric analyses of brain mris in patients with traumatic brain injury. J
Neuropsychiatry Clin Neurosci. 25, 32–39.
Ross, D.E., Ochs, A.L., Desmit, M.E., Seabaugh, J.M., Havranek, M.D., 2015. Alzheimer's
disease neuroimaging I. Man versus machine part 2: comparison of radiologists' in-
terpretations and neuroquant measures of brain asymmetry and progressive atrophy
in patients with traumatic brain injury. J Neuropsychiatry Clin Neurosci. 27,
147–152.
Scahill, R.I., Fox, N.C., 2007 Dec. Longitudinal imaging in dementia. Br J Radiol. 80,
S92–S98. https://doi.org/10.1259/bjr/78981552. Spec No 2.
Scheltens, P., Launer, L.J., Barkhof, F., Weinstein, H.C., van Gool, W.A., 1995. Visual
assessment of medial temporal lobe atrophy on magnetic resonance imaging:
Interobserver reliability. J. Neurol. 242, 557–560.
Scheltens, P., Erkinjunti, T., Leys, D., Wahlund, L.O., Inzitari, D., del Ser, T., et al., 1998.
White matter changes on ct and mri: an overview of visual rating scales. European
task force on age-related white matter changes. Eur. Neurol. 39, 80–89.
Van der Flier, W.M., Scheltens, P., 2005. Epidemiology and risk factors of dementia. J
Neurol Neurosurg Pyschiatry. 76 (Suppl. 5), v2–v7.
van Opbroek, A., Ikram, M.A., Vernooij, M.W., de Bruijne, M., 2015. Transfer learning
improves supervised image segmentation across imaging protocols. IEEE Trans. Med.
Imaging 34, 1018–1030.
Vernooij, M.W., Smits, M., 2012. Structural neuroimaging in aging and alzheimer's dis-
ease. Neuroimaging Clin. N. Am. 22, 33–55 (vii-viii).
Vibha, D., Tiemeier, H., Mirza, S.S., Adams, H.H.H., Niessen, W.J., et al., 2018. Brain
volumes and longitudinal cognitive change: a population-based study. Alzheimer Dis.
Assoc. Disord. 32, 43–49.
Vrooman, H.A., Cocosco, C.A., van der Lijn, F., Stokking, R., Ikram, M.A., Vernooij, M.W.,
et al., 2007. Multi-spectral brain tissue segmentation using automatically trained k-
nearest-neighbor classiﬁcation. NeuroImage 37, 71–81.
Wolz, R., Schwarz, A.J., Yu, P., Cole, P.E., Ruckert, D., Jack Jr., C.R., et al., 2014.
Robustness of automated hippocampal volumetry across magnetic resonance ﬁeld
strengths and repeat images. Alzheimers Dement. 10 430–438.e2.
M.W. Vernooij et al. NeuroImage: Clinical 20 (2018) 374–379
379
